Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Ambalal Sarabhai Enterprises Ltd. Share Price
Day's Range
Low
₹34.56
High
₹35.95
Price Summary
| Previous Close | ₹35.31 |
|---|---|
| Day's Range | ₹34.56 - ₹35.95 |
| Open | ₹34.75 |
| 52 Week Range | ₹30.15 - ₹49.98 |
| Volume | 3,556 |
| Market Cap | ₹0.00 |
| Previous Close | ₹35.00 |
|---|---|
| Day's Range | ₹34.85 - ₹35.90 |
| Open | ₹35.50 |
| 52 Week Range | ₹23.12 - ₹49.98 |
| Volume | 7,937 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 1.26 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 20.20 |
| TTM EPS (₹) | 1.77 |
| P/E Ratio | 10.45 |
| Book Value(₹) | 1.69 |
| PAT Margin (%) | 8.54 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 11.52 |
| Trade Value ( ₹ in Lacs) | 2.78 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 20.20 |
| TTM EPS (₹) | 1.77 |
| P/E Ratio | 10.45 |
| Book Value(₹) | 1.69 |
| PAT Margin (%) | 8.54 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 11.52 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 403.39 | 1961.85 |
| Expenses | N/A | N/A |
| PBT | 79.33 | 48.33 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 82.24 | 49.32 |
About Ambalal Sarabhai Enterprises Ltd.
| Founded | 1978 |
|---|---|
| Managing Director | Mohal K Sarabhai |
| NSE Symbol | AMBALALSA |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,21,803.09 | 1,762.95 | 1,583.70 - 1,583.70 |
| Divi's Laboratories Ltd. | 2,53,833.09 | 9,655.00 | 5,647.50 - 5,647.50 |
| Torrent Pharmaceuticals Ltd. | 1,73,461.06 | 4,564.10 | 3,532.60 - 3,532.60 |
| Lenskart Solutions Ltd. | 1,19,959.95 | 678.80 | 0.00 - 0.00 |
| Laurus Labs Ltd. | 1,18,055.52 | 2,245.00 | 917.95 - 917.95 |
| Apollo Hospitals Enterprise Ltd. | 1,17,040.71 | 8,198.00 | 6,696.50 - 6,696.50 |
| Zydus Lifesciences Ltd. | 1,16,907.45 | 1,186.00 | 835.50 - 835.50 |
| Dr. Reddy's Laboratories Ltd. | 1,11,463.21 | 1,338.50 | 1,101.00 - 1,101.00 |
| Cipla Ltd. | 1,09,870.40 | 1,357.00 | 1,165.70 - 1,165.70 |
| Mankind Pharma Ltd. | 1,02,583.88 | 2,461.20 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
iStreet Network informs about updates
Mercury Laboratories informs about board meeting
Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, Mercury Laboratories has informed that a meeting of the Board of Directors of the Company will be held on Thursday, November 05, 2026, to consider and approve the Unaudited Financial Results for the quarter and half year ended on September 30, 2026. Further, as per the Company’s Code of Conduct for Prevention of Insider Trading, the company has informed that, the ‘Trading Window’ has already been closed with effect from October 01, 2026 and shall continue to remain closed till 48 hours after the declaration of the unaudited financial results for the quarter and half year ended on September 30, 2026.
The above information is a part of company’s filings submitted to BSE.
Sudeep Pharma informs about newspapers publication
With reference to its Letter dated 28th October 2026 vide which it has submitted the unaudited Financial Results (Standalone and Consolidated) of the Company for the Second Quarter and half year ended 30th September 2026, Sudeep Pharma has submitted copies of the Extract of unaudited Financial Results of the Company for the Second Quarter and half year ended 30th September 2026, on Consolidated basis, published in Business Standard, English language newspaper, Ahmedabad, Gujarat Samachar and Vadodara Samachar, Regional language newspapers at Vadodara, Gujarat on 29th October 2026. The above information is also available on the Company’s website at https://www.sudeeppharma.com/.
The above information is a part of company’s filings submitted to BSE.
GKB Ophthalmics informs about board meeting
Biocon informs about press release
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Ambalal Sarabhai Enterprises Ltd. is ₹35.31 as of 2026-10-29.
The market capitalisation of Ambalal Sarabhai Enterprises Ltd. is ₹273.81 as of 2026-10-28.
The 1-year return of Ambalal Sarabhai Enterprises Ltd. is % as of .
The P/E ratio of Ambalal Sarabhai Enterprises Ltd. is 10.45 as of 2026-10-29.
The 52-week high and low of Ambalal Sarabhai Enterprises Ltd. are ₹49.98 and ₹30.15, respectively, as of 2026-10-29.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
